Jefferies (JEF) faces investor lawsuit over Point Bonita fund losses tied to First Brands fraud and bankruptcy.

Celldex (CLDX) stock surged as enrollments for a late-stage program for the lead asset barzolvolimab concluded ahead of schedule. Read more here.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Microsoft has warned that threat actors are exploiting seemingly legitimate Next. js repositories to compromise software developers, embedding staged backdoors inside projects that mimic technical ...